| The impact of prescription charges on asthma patients is uneven and unpredictable: evidence from qualitative interviews. | |
| | |
MedLine Citation:
|
PMID: 19484164 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIM: To explore whether, and how, prescription charges affect asthma patients' disease management behaviour. METHOD: Thirty qualitative interviews. RESULTS: Interviewees were aged between 21 and 59, 21 were women, 24 were paying individual prescription charges, and six had prepayment certificates (PPCs). Most had a beta2-agonist 'reliever' and a steroid 'preventer' inhaler. Prescription charges posed affordability issues for some, and for two patients cost-related reduction in 'preventer' use affected asthma control negatively. Many described various ways of keeping medication cost down. Affordability issues, negative views on paying charges, and whether interviewees viewed their asthma medication as essential, were influential factors. Steroid inhalers were viewed more commonly as being less essential and affected by cost. The episodic nature of asthma meant that predicting benefit from PPCs was difficult. CONCLUSION: This study strengthens existing evidence that medication cost is a factor in asthma patients' management decisions, with a potential cost-related impact on asthma control. |
| | |
Authors:
|
Ellen I Schafheutle |
Related Documents
:
|
19620024 - Reimbursed drugs in patients with sleep-disordered breathing: a static-charge-sensitive... 834514 - Cricoarytenoid arthritis and airway obstruction in juvenile rheumatoid arthritis. 17202024 - Treating asthma with a self-management model of illness behaviour in an australian comm... 12027064 - Stratifying asthma populations by medication use: how you count counts. 19831304 - Diverse biologies and experiential continuities: did the ancient chinese know that qing... 11825284 - Mapping between snomed rt and clinical terms version 3: a key component of the snomed c... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Primary care respiratory journal : journal of the General Practice Airways Group Volume: 18 ISSN: 1475-1534 ISO Abbreviation: Prim Care Respir J Publication Date: 2009 Dec |
Date Detail:
|
Created Date: 2009-11-30 Completed Date: 2010-02-25 Revised Date: 2010-06-03 |
Medline Journal Info:
|
Nlm Unique ID: 101121543 Medline TA: Prim Care Respir J Country: England |
Other Details:
|
Languages: eng Pagination: 266-72 Citation Subset: IM |
Affiliation:
|
School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK. ellen.schafheutle@manchester.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Inhalation Adult Anti-Asthmatic Agents / economics*, therapeutic use* Asthma / drug therapy*, economics* Decision Making Drug Costs* Female Great Britain Humans Interviews as Topic Male Middle Aged Nebulizers and Vaporizers / economics Patient Compliance Primary Health Care |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Asthmatic Agents |
| Comments/Corrections | |
Comment In:
|
Prim Care Respir J. 2010 Jun;19(2):189; author reply 190-1
[PMID:
20213050
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Minimum Information About a Microarray Experiment (MIAME) - Successes, Failures, Challenges.
Next Document: Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength...